Vapotherm, an Exeter, New Hampshire-based manufacturer of advanced respiratory care devices, closed a $24m financing round.
The round was led by Gilde Healthcare Partners, L.P., with participation new investor Adage Capital Management, L.P. and existing investors 3×5 Special Opportunity Fund, Morgenthaler Ventures, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital. In conjunction with the funding, Geoff Pardo, General Partner of Gilde Healthcare Partners, joined Vapotherm’s Board of Directors.
The company intends to use the funds to grow and improve healthcare for patients worldwide.
Led by Joe Army, President & CEO, Vapotherm develops innovative, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders.
Over 600,000 patients have been treated with Vapotherm high flow therapy.